QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
February 25, 2025
February 25, 2025
SAN DIEGO, California, Feb. 25 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release on Feb. 24, 2025:
* * *
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
SAN DIEGO--QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho"), a global provider of innovative in-vitro diagnostic technolo . . .
* * *
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
SAN DIEGO--QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho"), a global provider of innovative in-vitro diagnostic technolo . . .